Fingerprint
Dive into the research topics of 'Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically